Point of Care Diagnostics

Report Code: HLC043B

Publish Date: Nov 2009

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Global POC market was worth nearly $13.4 billion in 2009, it is estimated to increase to $18.7 billion, at 5 year compound annual growth rate (CAGR) of 7.0%.
  • The largest test blood chemistry and electrolyte market was nearly $2.1 billion in 2009. This is expected to rise to $3.8 billion in 2014, at a CAGR of 12.0%.
  • Glucose monitoring test market reached approximately $7.7 million in 2009 and is projected to reach $9.9 billion in 2014, at a CAGR of 5.1%.

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
The goal of this study on the point-of-care (POC) industry is to describe this flourishing near-patient testing market. This report provides a complete review and analysis of the current POC markets as well as forecasts the market through 2014 in constant dollars. In addition, it provides an examination and description of products, current and emerging technologies, and company profiles.
The study also covers federal regulation of POC testing, international developments, and patents for POC testing technologies.
REASONS FOR DOING THE STUDY
 
Over the last few decades, there has been a strong trend toward POC testing due to an increasing demand for near-patient testing that provides rapid results. More tests are being performed at the hospital patient’s bedside, in physicians’ office laboratories, outpatient clinics, emergency rooms, and intensive-care units. Critical-care instruments combining selected important chemistry, hematology and hemostasis parameters have entered the market for POC testing in the emergency and operating rooms.
The wider availability of POC testing has revolutionized the continuum of the patient-care process by providing laboratory results rapidly and efficiently at these locations. The trend toward greater POC testing is driven by the faster diagnostic benefits it provides. 
Several reasons have emerged for this demand of POC testing, including staff shortages, older populations, long-term cost savings, faster diagnosis and care, and rural locations without conventional laboratory services. This study will address these areas and others.
SCOPE OF REPORT
 
This study will describe the market for POC Diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players. Specifically, the report:
  • Describes the POC industry.
  • Estimates the current and future market size.
  • Provides breakdowns for U.S. markets.
  • Describes product segments and the continuous updating of POC products.
  • Analyzes market influences in the industry and predicts the changes that will shape the future POC market.
  • Discusses trends within the market and provides a future outlook
  • Reviews business activities of market leaders.
  • Lists patents for POC technologies.
DEFINING POC 
For the purpose of this study, POC testing includes those tests that are used outside the traditional laboratory. This can be a range of users, including patients, physicians, outpatient clinics, community health centers, and pharmacies. Tests included in this report are those that do not require any specialized training to perform and are performed easily and results produced in a minimal time frame.
METHODOLOGY
 
The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with key representatives in the industry – product development managers, clinical specialists, government departments, and other key representatives involved in the diagnostic industry. 
Secondary methods included published literature, investment reports, company literature, and various business journals that focus on diagnostic products and technologies.
Market data for this report pertains to the worldwide market, with specific U.S. data included. All information is displayed using U.S. dollars at the manufacturers’ level. The base year of the report is 2009, with historical data provided for 2007 and 2008, and forecast data provided through 2014. Historical, base year, and forecast data are provided for each of the 10 market segments in the report. Compound annual growth rates (CAGRs) are determined through a compilation of data, including past trends, future trends, demographics, incidence of disease, products in research and development, current product growth, and trends in government regulations.  Competitor market share estimates are provided for each market segment for the 2009 base year.
ANALYST CREDENTIALS
 
Melissa Elder is an experienced healthcare market analyst, specializing in prescription and over-the-counter pharmaceuticals, medical devices, animal health products, and emerging healthcare technologies. Ms. Elder has more than 13 years of experience in the healthcare industry, specializing in market research for the past 10 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.  
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Point of Care Diagnostics150Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: INDUSTRY OVERVIEW26Free
Chapter- 4: THE POC MARKET80Free
Chapter- 5: TECHNOLOGY APPLICATIONS3Free
Chapter- 6: PATENT ANALYSIS9Free
Chapter- 7: WORLDWIDE POC MARKET6Free
Chapter- 8: PROFILES OF MAJOR MARKET PARTICIPANTS14Free
Chapter- 9: APPENDIX5Free
Published - Feb-2006| Analyst - Barbara Breindel| Code - HLC043A

Report Highlights

  • POC testing revenue reached an estimated $5.05 billion in 2005 and is expected to grow at a 13.8% AAGR through 2010, yielding sales of nearly $9.65 billion.
  • A major force driving the growth of this industry is the effort to provide better patient care by improving the time to treatment (TAT) that POC testing offers. Other forces include cost containment, the aging population, the increased incidence of certain diseases, and technological advances.
  • Glucose testing meters and supplies accounted for 47.9% of POC sales in 2005 and are expected to grow at a 9.4% AAGR through 2010. The worldwide incidence of diabetes is predicted to double in the next 25 years.

Related Reports

Recent Reports

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - HLC071E

The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.

Microelectronic Medical Implants: Products, Technologies & Opportunities

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC016F

The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029. 

Wearable Medical Devices: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC192D

The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Synthetic Biology: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

Electric Vehicles and Fuel Cell Vehicles: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - FCB040F

The global market for electric vehicles and fuel cell vehicles was valued at $655.9 billion in 2023. The market is expected to grow from $758.0 billion in 2024 to $1.8 trillion by 2029, at a compound annual growth rate (CAGR) of 18.6% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Point of Care Diagnostics
Customize Report